Coeptis Therapeutics Holdings Inc
COEPW0.018USD
+0.004+25.00%
Close 11/07, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Coeptis Therapeutics Holdings Inc Company
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and advanced robotic process automation capabilities. Its Coeptis Technologies division is focused on diversifying and enhancing its growth potential. Its subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.
Coeptis Therapeutics Holdings Inc Info
Ticker SymbolCOEPW
Company nameCoeptis Therapeutics Holdings Inc
IPO dateDec 17, 2020
CEO- -
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address105 Bradford Road, Suite 420
CityWEXFORD
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code15090
Phone17249346467
Websitehttps://coeptistx.com/
Ticker SymbolCOEPW
IPO dateDec 17, 2020
CEO- -
Company Executives of Coeptis Therapeutics Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. David Mehalick
Mr. David Mehalick
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Ms. Christine Sheehy
Ms. Christine Sheehy
Vice President - Compliance, Secretary
Vice President - Compliance, Secretary
--
--
Mr. Christopher Calise
Mr. Christopher Calise
Independent Director
Independent Director
--
--
Mr. Christopher Cochran
Mr. Christopher Cochran
Independent Director
Independent Director
--
--
Mr. Philippe Deschamps
Mr. Philippe Deschamps
Independent Director
Independent Director
--
--
Dr. Tara Maria Desilva, Ph.D.
Dr. Tara Maria Desilva, Ph.D.
Independent Director
Independent Director
--
--
Mr. Brian Cogley
Mr. Brian Cogley
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Daniel (Dan) Yerace
Mr. Daniel (Dan) Yerace
Vice President - Operations, Director
Vice President - Operations, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David Mehalick
Mr. David Mehalick
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Ms. Christine Sheehy
Ms. Christine Sheehy
Vice President - Compliance, Secretary
Vice President - Compliance, Secretary
--
--
Mr. Christopher Calise
Mr. Christopher Calise
Independent Director
Independent Director
--
--
Mr. Christopher Cochran
Mr. Christopher Cochran
Independent Director
Independent Director
--
--
Mr. Philippe Deschamps
Mr. Philippe Deschamps
Independent Director
Independent Director
--
--
Dr. Tara Maria Desilva, Ph.D.
Dr. Tara Maria Desilva, Ph.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Thu, Oct 2
Updated: Thu, Oct 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
25
918.20K
0.00%
-367.10K
2025Q2
25
830.98K
0.00%
-949.99K
2025Q1
26
830.98K
0.00%
-1.05M
2024Q4
29
1.01M
0.00%
-1.53M
2024Q3
33
1.78M
0.00%
-1.61M
2024Q2
34
2.07M
0.00%
-1.33M
2024Q1
34
2.12M
0.00%
-666.88K
2023Q4
33
1.49M
0.00%
-1.25M
2023Q3
31
1.50M
0.00%
-1.41M
2023Q2
30
2.00M
0.00%
-919.99K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Clear Street LLC
200.00
0%
+200.00
--
Jun 30, 2025
IONIC Capital Management, L.L.C.
--
0%
-93.56K
-100.00%
Dec 31, 2024
TD Securities, Inc.
44.95K
0%
+44.95K
--
Jun 30, 2025
Susquehanna International Group, LLP
54.68K
0%
+54.68K
--
Jun 30, 2025
Meteora Capital LLC
250.00K
0%
-2.23K
-0.88%
Jun 30, 2025
RiverNorth Capital Management LLC
149.90K
0%
-100.00
-0.07%
Jun 30, 2025
Walleye Trading, LLC
130.17K
0%
-1.10K
-0.84%
Jun 30, 2025
Cantor Fitzgerald, L.P
106.46K
0%
--
--
Jun 30, 2025
Skyview Investment Advisors, LLC
55.12K
0%
--
--
Jun 30, 2025
CSS, LLC
38.85K
0%
--
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
